(Q53270014)
Statements
β-receptor antagonist treatment prevents activation of cell death signaling in the diabetic heart independent of its metabolic actions. (English)
Vijay Sharma
Arpeeta Sharma
Varun Saran
Pascal N Bernatchez
Michael F Allard
John H McNeill
4 February 2011
657
1-3
117-125